Recombinant Human LIF

Description

EnkiLife provides the Recombinant Human LIF protein,aslo know as Leukemia Inhibitory Factor,LIF,Differentiation-Stimulating Factor,D Factor,Melanoma-Derived LPL Inhibitor,MLPLI,Emfilermin,LIF,HILDA, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<0.01 EU/µg as determined by LAL test.;Construction:Recombinant Human Leukemia Inhibitory Factor is produced by our E.coli expression system and the target gene encoding Ser23-Phe202 is expressed.Accession:P15018. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:19.7 KDa. Background:Leukemia Inhibitory Factor (LIF) is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo. Human and murine mature LIF exhibit a 78% sequence identity at the amino acid level. Human LIF is equally active on human and mouse cells. Murine LIF is approximately 1000 fold less active on human cells than human LIF.